Literature DB >> 7671544

The role of nitric oxide, endothelin, and prostaglandins in the transition of the pulmonary circulation.

J W Ziegler1, D D Ivy, J P Kinsella, S H Abman.   

Abstract

This review emphasizes the importance of three endothelial-derived products in regulating fetal and transitional pulmonary vascular tone. Although the pathophysiologic events that culminate in PPHN are poorly understood, it is likely that endothelial cell dysfunction, with an alteration in the normal "balance" of endothelial-derived mediators, is a contributing factor. In addition to the three vasoactive mediators described herein, several other neurohumoral agents influence fetal and transitional pulmonary vascular tone. In addition, structural changes in the pulmonary circulation, with abnormal proliferation of smooth muscle and extracellular matrix components, also contribute to failure of normal postnatal adaptation. Continued research is necessary to better define the complex interactions that result in the normal transition from the fetal to the postnatal state. Continued advances in the understanding of the normal transition will allow a more rational approach to management of the failed transition reflected in the disease state, PPHN.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7671544

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  9 in total

Review 1.  Exhaled breath measures of inflammation: are they useful in neonatal chronic lung disease?

Authors:  C M Harrison; C C Andersen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

2.  Range of echocardiographic findings in term neonates with high oxygen requirements.

Authors:  N Evans; M Kluckow; A Currie
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-03       Impact factor: 5.747

Review 3.  Persistent pulmonary hypertension of the newborn: pathogenesis, etiology, and management.

Authors:  Enrique M Ostrea; Esterlita T Villanueva-Uy; Girija Natarajan; Herbert G Uy
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

4.  Endothelin-A receptor blockade prevents and partially reverses neonatal hypoxic pulmonary vascular remodeling.

Authors:  Namasivayam Ambalavanan; Arlene Bulger; Joanne Murphy-Ullrich; Suzanne Oparil; Yiu-Fai Chen
Journal:  Pediatr Res       Date:  2005-03-17       Impact factor: 3.756

5.  Improvement of oxygenation induced by aerosolized prostacyclin in a preterm infant with persistent pulmonary hypertension of the newborn.

Authors:  V Soditt; C Aring; P Groneck
Journal:  Intensive Care Med       Date:  1997-12       Impact factor: 17.440

6.  Exhaled nitric oxide levels in infants with chronic lung disease.

Authors:  Jaana A Leipälä; Olivia Williams; Sanya Sreekumar; Paul Cheeseman; Gerrard F Rafferty; Simon Hannam; Anthony Milner; Anne Greenough
Journal:  Eur J Pediatr       Date:  2004-06-17       Impact factor: 3.183

7.  Endothelin-1 mediates hypoxia-induced increases in vascular collagen in the newborn mouse lung.

Authors:  Namasivayam Ambalavanan; Peng Li; Arlene Bulger; Joanne Murphy-Ullrich; Suzanne Oparil; Yiu-Fai Chen
Journal:  Pediatr Res       Date:  2007-05       Impact factor: 3.756

Review 8.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

Review 9.  Molecular physiopathogenetic mechanisms and development of new potential therapeutic strategies in persistent pulmonary hypertension of the newborn.

Authors:  Giuseppe Distefano; Pietro Sciacca
Journal:  Ital J Pediatr       Date:  2015-02-08       Impact factor: 2.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.